{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:59Z","timestamp":1792511279076,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T00:00:00Z","timestamp":1504310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","award":["MSD-SORCOM"],"award-info":[{"award-number":["MSD-SORCOM"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00296-017-3799-x","type":"journal-article","created":{"date-parts":[[2017,9,2]],"date-time":"2017-09-02T08:21:36Z","timestamp":1504340496000},"page":"1853-1861","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7152-0458","authenticated-orcid":false,"given":"Laura","family":"Nu\u00f1o-Nu\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Esther","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia E.","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Maldonado-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Larena-Grijalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Llorente","family":"Cubas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Gloria","family":"Tomero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Carmen","family":"Barbadillo-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma Garc\u00eda","family":"De la Pe\u00f1a Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Ruiz-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"L\u00f3pez-Robledillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Moruno-Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Cobo-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Almod\u00f3var Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"Lojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Garc\u00eda De Y\u00e9benes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"L\u00f3pez-Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,2]]},"reference":[{"key":"3799_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/rheumatology\/keu289","volume":"54","author":"A Meyer","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J (2015) Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford) 54:50\u201363","journal-title":"Rheumatology (Oxford)"},{"key":"3799_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S0889-857X(02)00021-2","volume":"28","author":"FL Mastaglia","year":"2002","unstructured":"Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28:723\u2013741","journal-title":"Rheum Dis Clin North Am"},{"key":"3799_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780140210","volume":"14","author":"TA Medsger Jr","year":"1971","unstructured":"Medsger TA Jr, Robinson H, Masi AT (1971) Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum 14:249\u2013258","journal-title":"Arthritis Rheum"},{"key":"3799_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780280303","volume":"28","author":"J Benbassat","year":"1985","unstructured":"Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A (1985) Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 28:249\u2013255","journal-title":"Arthritis Rheum"},{"key":"3799_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","volume":"83","author":"K Danko","year":"2004","unstructured":"Danko K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35\u201342","journal-title":"Medicine (Baltimore)"},{"key":"3799_CR6","first-page":"S109","volume":"26","author":"IE Lundberg","year":"2008","unstructured":"Lundberg IE, Forbess CJ (2008) Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 26:S109\u2013S114","journal-title":"Clin Exp Rheumatol"},{"key":"3799_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08916930600622603","volume":"39","author":"C Torres","year":"2006","unstructured":"Torres C, Belmonte R, Carmona L et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39:205\u2013215","journal-title":"Autoimmunity"},{"key":"3799_CR8","doi-asserted-by":"publisher","first-page":"e1144","DOI":"10.1097\/MD.0000000000001144","volume":"94","author":"L Cavagna","year":"2015","unstructured":"Cavagna L, Nuno L, Scire CA et al (2015) Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study. Medicine (Baltimore) 94:e1144","journal-title":"Medicine (Baltimore)"},{"key":"3799_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","volume":"25","author":"A Airio","year":"2006","unstructured":"Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234\u2013239","journal-title":"Clin Rheumatol"},{"key":"3799_CR10","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3899\/jrheum.151425","volume":"43","author":"KJ Bhansing","year":"2016","unstructured":"Bhansing KJ, van Riel PL, van Engelen BG, Fransen J, Vonk MC (2016) Patients with systemic sclerosis\/polymyositis overlap have a worse survival rate than patients without it. J Rheumatol 43:1838\u20131843","journal-title":"J Rheumatol"},{"key":"3799_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2016.07.010","author":"L Nu\u00f1o","year":"2016","unstructured":"Nu\u00f1o L, Joven B, Carreira P (2016) Multicenter registry on inflammatory myositis from the rheumatology society in Madrid, Spain: descriptive analysis. Reumatol Clin. doi:\n                    10.1016\/j.reuma.2016.07.010","journal-title":"Reumatol Clin"},{"key":"3799_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"3799_CR13","first-page":"668","volume":"22","author":"K Tanimoto","year":"1995","unstructured":"Tanimoto K, Nakano K, Kano S et al (1995) Classification criteria for polymyositis and dermatomyositis. J Rheumatol 22:668\u2013674","journal-title":"J Rheumatol"},{"key":"3799_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1987","unstructured":"Arnett FC, Edworthy SM, The Bloch DA, Association American Rheumatism et al (1987) revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"3799_CR15","doi-asserted-by":"crossref","unstructured":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum. 23:581\u2013590","DOI":"10.1002\/art.1780230510"},{"key":"3799_CR16","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725","journal-title":"Arthritis Rheum"},{"key":"3799_CR17","first-page":"328","volume":"16","author":"D Alarcon-Segovia","year":"1989","unstructured":"Alarcon-Segovia D, Cardiel MH (1989) Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 16:328\u2013334","journal-title":"J Rheumatol"},{"key":"3799_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/art.1780290501","volume":"29","author":"RI Fox","year":"1986","unstructured":"Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV (1986) Sjogren\u2019s syndrome. Proposed criteria for classification. Arthritis Rheum 29:577\u2013585","journal-title":"Arthritis Rheum"},{"key":"3799_CR19","first-page":"438","volume":"35","author":"C Andras","year":"2008","unstructured":"Andras C, Ponyi A, Constantin T et al (2008) Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35:438\u2013444","journal-title":"J Rheumatol"},{"key":"3799_CR20","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.autrev.2014.08.023","volume":"13","author":"MG Danieli","year":"2014","unstructured":"Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A (2014) A impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. Autoimmun Rev 13:1048\u20131054","journal-title":"Autoimmun Rev"},{"key":"3799_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11926-012-0249-3","volume":"14","author":"I Marie","year":"2012","unstructured":"Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275\u2013285","journal-title":"Curr Rheumatol Rep"},{"key":"3799_CR22","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3899\/jrheum.101002","volume":"38","author":"Y Yamasaki","year":"2011","unstructured":"Yamasaki Y, Yamada H, Ohkubo M et al (2011) Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 38:1636\u20131643","journal-title":"J Rheumatol"},{"key":"3799_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12016-015-8511-x","volume":"52","author":"E Tiniakou","year":"2017","unstructured":"Tiniakou E, Mammen AL (2017) Idiopathic inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allergy Immunol 52:20\u201333","journal-title":"Clin Rev Allergy Immunol"},{"key":"3799_CR24","first-page":"820","volume":"34","author":"M Amaral Silva","year":"2016","unstructured":"Amaral Silva M, Cogollo E, Isenberg DA (2016) Why do patients with myositis die? A retrospective analysis of a single-centre cohort. Clin Exp Rheumatol 34:820\u2013826","journal-title":"Clin Exp Rheumatol"},{"key":"3799_CR25","first-page":"2230","volume":"28","author":"I Marie","year":"2001","unstructured":"Marie I, Hachulla E, Hatron PY et al (2001) Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28:2230\u20132237","journal-title":"J Rheumatol"},{"key":"3799_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41:22\u201326","journal-title":"Rheumatology (Oxford)"},{"key":"3799_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1445-5994.2010.02406.x","volume":"42","author":"V Limaye","year":"2012","unstructured":"Limaye V, Hakendorf P, Woodman RJ, Blumbergs P, Roberts-Thomson P (2012) Mortality and its predominant causes in a large cohort of patients with biopsy-determined inflammatory myositis. Intern Med J 42:191\u2013198","journal-title":"Intern Med J"},{"key":"3799_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.semarthrit.2010.08.003","volume":"41","author":"I Marie","year":"2011","unstructured":"Marie I, Menard JF, Hachulla E et al (2011) Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum 41:48\u201360","journal-title":"Semin Arthritis Rheum"},{"key":"3799_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/14397595.2015.1054081","volume":"26","author":"M Ishizuka","year":"2016","unstructured":"Ishizuka M, Watanabe R, Ishii T et al (2016) Long-term follow-up of 124 patients with polymyositis and dermatomyositis: statistical analysis of prognostic factors. Mod Rheumatol 26:115\u2013120","journal-title":"Mod Rheumatol"},{"key":"3799_CR30","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1002\/art.30513","volume":"63","author":"I Marie","year":"2011","unstructured":"Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63:3439\u20133447","journal-title":"Arthritis Rheum"},{"key":"3799_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10067-009-1110-6","volume":"28","author":"IJ Chen","year":"2009","unstructured":"Chen IJ, Jan Wu YJ, Lin CW et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28:639\u2013646","journal-title":"Clin Rheumatol"},{"key":"3799_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10067-015-3139-z","volume":"35","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang CS, Li YJ et al (2016) Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis. Clin Rheumatol 35:113\u2013116","journal-title":"Clin Rheumatol"},{"key":"3799_CR33","doi-asserted-by":"publisher","first-page":"e94128","DOI":"10.1371\/journal.pone.0094128","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Yang H, Shu X et al (2014) Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis. PLoS ONE 9:e94128","journal-title":"PLoS ONE"},{"key":"3799_CR34","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10067-014-2730-z","volume":"33","author":"LA Aguila","year":"2014","unstructured":"Aguila LA, Lopes MR, Pretti FZ et al (2014) Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis. Clin Rheumatol 33:1093\u20131098","journal-title":"Clin Rheumatol"},{"key":"3799_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/03009742.2013.868512","volume":"43","author":"M Jung","year":"2014","unstructured":"Jung M, Bonner A, Hudson M, Baron M, Pope JE (2014) Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian scleroderma research group (CSRG) cohort. Scand J Rheumatol 43:217\u2013220","journal-title":"Scand J Rheumatol"},{"key":"3799_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/0049-0172(86)90014-4","volume":"15","author":"MC Hochberg","year":"1986","unstructured":"Hochberg MC, Feldman D, Stevens MB (1986) Adult onset polymyositis\/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 15:168\u2013178","journal-title":"Semin Arthritis Rheum"},{"key":"3799_CR37","first-page":"263","volume":"14","author":"YM Maugars","year":"1996","unstructured":"Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM (1996) Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol 14:263\u2013274","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-017-3799-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-017-3799-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T15:23:42Z","timestamp":1552663422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-017-3799-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,2]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3799"],"URL":"https:\/\/doi.org\/10.1007\/s00296-017-3799-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,2]]},"assertion":[{"value":"21 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study does not contain any studies with animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Laura Nu\u00f1o-Nu\u00f1o has received a research grant from MSD. Francisco Javier L\u00f3pez-Longo has received speaker fees from Roche, Bristol-Myers Squibb, UCB and GSK. Beatriz Joven, Patricia Carreira, Valentina Maldonado-Romero, Carmen Larena-Grijalba, Irene Llorente-Cubas, Eva Tomero, Mar\u00eda Carmen Barbadillo-Mateos, Paloma Garc\u00eda de la Pe\u00f1a Lefebvre, Luc\u00eda Ruiz-Guti\u00e9rrez, Juan Carlos L\u00f3pez-Robledillo, Henry Moruno-Cruz, Ana P\u00e9rez-G\u00f3mez, Tatiana Cobo-Ib\u00e1\u00f1ez, Raquel Almod\u00f3var, Leticia Lojo-Oliveira, and Mar\u00eda Jes\u00fas Garc\u00eda-de Y\u00e9benes declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was partially funded with a grant from MSD (MSD-SORCOM).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}